NCT00626496 Family Study of Lymphoproliferative Disorders
| NCT ID | NCT00626496 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Lymphoma, Non-Hodgkin |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2004-04-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2004-04-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
Eligibility Criteria
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Contact & Investigator
Susan Slager, Ph.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT00626496 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Lymphoma, Non-Hodgkin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00626496 currently recruiting?
Yes, NCT00626496 is actively recruiting participants. Contact the research team at Erding.Catherine@mayo.edu for enrollment information.
Where is the NCT00626496 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT00626496 clinical trial?
NCT00626496 is sponsored by Mayo Clinic. The principal investigator is Susan Slager, Ph.D. at Mayo Clinic. The trial plans to enroll 3,000 participants.